1 / 5

Cardiac Monitoring Market Size, Share, Growth, and Demand Forecast to 2030

In 2021, the cardiac monitoring market was dominated by North America, accounting for $2,998.3 million, and this trend will be exhibited in the forecast period as well, advancing at a CAGR of 8.7%.

psmarket
Télécharger la présentation

Cardiac Monitoring Market Size, Share, Growth, and Demand Forecast to 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cardiac Monitoring Market Size, Share, Growth, Development and Demand Forecast to 2030 1 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  2. By 2030, the cardiac monitoring market is predicted to touch $16,124 million, from $7,965.7 million in 2021. The market is projected to advance at a CAGR of 8.2% from 2021 to 2030, owing to the escalating prevalence of cardiovascular diseases, which is the major reason for death globally, accounting for about 17.9 million deaths per year. Alcohol consumption, imbalanced diet, diabetes, lack of physical activity, obesity, rising cholesterol levels, and extensive tobacco use are some of the factors that directly impact the health of the heart. A paradigm shift in the pattern of lifestyle has emphasized the dire need to consistently monitor cardiac health. As a result, numerous products are launched in the cardiac monitoring market. For example, Biotricity Inc. launched Bioheart, a heart monitor that assists in consistent rhythmic monitoring for two days on a full battery, in November 2021. Moreover, to reduce the prevalence of cardiovascular diseases, pre-diagnosis and pre-monitoring must be done effectively. The most-usual arrhythmia diagnosed during clinical practices is atrial fibrillation (AFib). In 2021, approximately 6.1 million cases of AFib were found in the U.S., and this number is predicted to surge to 12.1 million cases by 2030. Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/cardiac- monitoring-market/report-sample Moreover, fast technological developments will spur cardiac monitoring market growth. Cardiac monitoring practices and mobile cardiac telemetry (MCT) will become much better with gradual developments in heart monitoring devices. For instance, the next-generation RhythmStar wearable device accompanied by in- built 4G cellular connectivity was launched by RhythMedix LLC in February 2021. Without the requirement of any communication device, such as a phone, the cardiac telemetry monitor is developed for correct and extended evaluation of cardiac rhythm in real-time. Furthermore, the rising integration of digital health services in a digital era will drive the market. Within the product segment, approximately 38% of the total revenue share in the cardiac monitoring market in 2021 was held by the resting ECG category. This is credited to the improved and swift diagnosis of cardiac health through these devices over the long-term and short-term monitoring systems. Moreover, the costs of the resting ECG devices are lower than others in comparison. Furthermore, these devices can also be used with different medical procedures, telemetry monitoring equipment, and cardiac diagnostic tests. In 2021, $3,070.3 million revenue was generated by hospitals, and it is predicted that the category will advance at a 7.8% CAGR from 2021 to 2030. This is because of the increasing count of patient visits to hospitals, surging count of cardiac device implantation procedures, escalating prevalence of 2 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  3. cardiovascular diseases, and convenient availability of reimbursement for these procedures. Every year, around 7% of patients with a history of myocardial infarction or with coronary artery diseases visit hospitals in the U.S., whereas approximately 7% of patients with heart illnesses attend emergency departments. In 2021, the cardiac monitoring market was dominated by North America, accounting for $2,998.3 million, and this trend will be exhibited in the forecast period as well, advancing at a CAGR of 8.7%. This can be ascribed to the greater integration of technologically developed devices, rising healthcare awareness, surging disposable income, mounting healthcare expenditure, and increasing prevalence of cardiovascular diseases. For instance, in 2020, U.S. adults diagnosed with coronary heart disease were 4.6% of the total population. Browse full report at: https://www.psmarketresearch.com/market- analysis/cardiac-monitoring-market Hence, the escalating prevalence of cardiovascular diseases and the surging adoption of technologically advanced devices will drive the market. Cardiac Monitoring Market Size Breakdown by Segment Based on Product Resting ECG Stress ECG MCT Holter Monitoring ICM Monitoring Cardiac Event Monitoring Cardiac Output Monitoring • • • • • • • Based on Mode Standard Ambulatory • • Based on End User Hospitals Specialty Cardiac Centers & Clinics Diagnostic Centers • • • Geographical Analysis 3 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  4. North America oU.S. oCanada Europe oU.K. oGermany oFrance oSpain oItaly Asia-Pacific oChina oIndia oJapan oSouth Korea oAustralia Latin America oBrazil oMexico oArgentina Middle East and Africa oTurkey oSaudi Arabia oSouth Africa • • • • • 4 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  5. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 4 ©P&SIntelligence.Allrightsreserved 5 © Prescient & Strategic Intelligence Private Limited. All rights reserved

More Related